Projects granted during 2014 that have a primary purpose of translational and applied research: human nervous and mental disorders.
PDF, 289KB, 35 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
This document outlines the projects granted under the Animals (Scientific Procedures) Act 1986 during 2014 with a primary purpose of translational and applied research: human nervous and mental disorders.
The following projects were granted:
- microdialysis to profile novel drugs (drugs, CNS, mode of action)
- schwann cell development and function (schwann, regeneration, myelination, schwannoma, nervous system)
- novel treatments for CNS disorders (neuropsychiatric; neurodegeneration; models; treatment; neurochemistry)
- modelling and therapeutics for neurodegeneration (motor neurone disease, gene therapy)
- investigations into disorders of movement (Parkinson’s, dystonia, neurodegeneration, movement, dyskinesia)
- development of novel analgesics (analgesia, inflammatory pain, neuropathic pain)
- understanding cerebral folate metabolism (hydrocephalus, brain development, folate)
- mechanisms and treatments for neuropsychiatric diseases (schizophrenia, cognition, brain imaging, pharmacology)